FDA grants AP status for Quetiapine Fumarate ANDA206252 by Accord Healthcare
The FDA has granted approval status (AP) for the ANDA206252 application for Quetiapine Fumarate submitted by Accord Healthcare.
Asset / Drug
Drug and asset intelligence for Quetiapine with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.